Objective: Aortic valve sclerosis (AVS) is a progressive disease that is characterized by aortic valve thickening without causing significant narrowing and in which pathology resembles atherosclerotic coronary heart disease. We aimed to evaluate the relationship between AVS and platelet indices including mean platelet volume (MPV), platelet distribution weight (PDW), and platelet count. Method: Two hundred ten patients who were evaluated in the echocardiography unit due to various reasons between January and October 2008 were consecutively included in the study. The patients were divided into 2 groups according to presence or absence of AVS. The patient group consisted of 150 patients (76 females and 74 males; mean age, 64.5 + 11.5 years). Patients without AVS (24 females and 36 males; mean age, 49.8 + 15.7 years) were assigned as control group. The MPV, PDW, and platelet count were measured. Results: The MPV (9.56 + 1.3 fL vs 9.15 + 1.0 fL, P ¼ .022) and PDW (16.9 + 2.3% vs 14.9 + 2.3, P ¼ .001) were significantly higher in patients with AVS (þ) compared to the AVS (À) group. No significant difference was demonstrated between the groups in terms of white blood cell and platelet counts (P > .05). When the AVS (þ) group was compared to the AVS (À) group, a significant difference was found in respect of hypertension, diabetes mellitus, and smoking status. Conclusion: Platelet production indices including MPV and PDW were increased in patients with AVS. The complex interrelationship between increased platelet production indices and AVS and value of antithrombotic therapies in patients with AVS need to be evaluated in further studies.
Introduction
Aortic valve sclerosis (AVS) is diagnosed by demonstrating fibrocalcifications or thickening in the aortic valves without causing any obstruction or demonstrating increased valvular echogenicity via echocardiography. As such, the mobility of the valves is normal. 1 There are numerous published studies suggesting that age, diabetes mellitus (DM), hypertension (HT), and increased weight, which are risk factors for atherosclerotic heart disease, are also risk factors for AVS. 2 Assessment of the activity of platelets indirectly by the measurement of morphologic parameters, such as the mean platelet volume (MPV), the platelet distribution weight (PDW), and the platelet count, have been suggested in numerous studies. [3] [4] [5] [6] The pathophysiology of AVS in the early stages has been reported to demonstrate some features similar to that in acute coronary syndrome and is associated with increased platelet aggregation. [7] [8] [9] Moreover, it has been reported that increased thrombotic activity and the formation of thrombi may occur in calcified and stenotic valves of patients with AVS. [10] [11] [12] An abnormal increase in platelet count is believed to be one of the early steps preceding the occurrence of atherosclerosis. The earliest observed alterations during thrombus formation are the formation of plaque rupture due to various factors, adhesion of platelets to subendothelial collagen tissue, and subsequent activation. The damage in endothelial cells of atherosclerotic plaques results from the aggregation of platelets. Mean platelet volume and PDW are detected easily by a routine complete blood count (CBC) test. Mean platelet volume and PDW also increase when there is an increase in platelet production. A platelet volume >10 fL indicates large platelets and values <6 fL indicate small platelets. Platelets play an important role in the pathophysiology of atherosclerotic diseases. Alterations in platelet volume are reported to be predictive for thrombotic and prethrombotic events and possibly have diagnostic value. 13 The purpose of the current study was to evaluate the relationship between AVS and platelet indices including MPV, PDW, and platelet count.
Methods
Two hundred ten patients who were evaluated in the echocardiography unit for various reasons between January and October 2008 were consecutively included in the study. The patients were divided into 2 groups according to presence or absence of AVS. The patient group consisted of 150 patients (76 females and 74 males; mean age, 64.5 + 11.5 years) who were determined to have AVS (AVSþ) by echocardiography. Patients without AVS (AVSÀ; 24 females and 36 males; mean age, 49.8 + 15.7 years) were assigned as control group. Transthoracic echocardiography (TTE) was performed on all patients. Systolic and diastolic blood pressures at rest and blood samples following a 12-hour fast were obtained. The MPV, PDW, platelet count, white blood cell (WBC) count, blood glucose level, total cholesterol (TC), high-density lipoprotein cholesterol (HDL)-C, low-density lipoprotein cholesterol (LDL)-C, and triglycerides (TG) were measured.
The exclusion criteria for the study were the following: known atherosclerotic disease, cardiac insufficiency, rheumatic valvular disease, aortic insufficiency (>1/4) and stenosis, use of lipid-lowering agents, a prosthetic valve, chronic renal disease, and inconclusive TTE imaging.
Echocardiographic Findings
Echocardiographic measurements of all patients were obtained in the left lateral decubitus position according to the criteria of the American Society of Echocardiography via TTE by 2 cardiologists who were blind to the clinical information of the patients using a VIVID 7 echocardiography device (General Electric Vivid 7 GE Vingmed Ultrasound AS, Horten, Norway). 14 Aortic valve assessments were acquired from parasternal long-short axis and apical long-axis recordings. The ejection fraction (EF %) was calculated according to the Teichholz formula. The left ventricular mass index (LVMI) was acquired by dividing the obtained values of the LVM, which was calculated according to the Devereux formula, to the body surface area. 15 
Risk Factors
In this study, HT, DM, and smoking were considered as risk factors for AVS. Patients who had hyperglycemia (>126 mg/ dL) on blood tests or those receiving anti-diabetic agents were assumed as DM. Patients who had systolic/diastolic blood pressure values >140 mm Hg/90 mm Hg, and those using antihypertensive agents were accepted as HT.
Laboratory Measurements
In all patients, blood samples were drawn from the antecubital vein following a 12-hour fast. The levels of fasting blood glucose, serum TC, TG, HDL-C, and LDL-C were measured. All routine biochemical tests were carried out on an autoanalyser (Roche Diagnostic Modular Systems, Tokyo, Japan). For analysis of the MPV, blood samples with K3 EDTA were processed by a Sysmex XT-2000i analyzer (Sysmex, Kobe, Japan).
Anthropometric Measurements
Body weight and height measurements were measured with patients who were fasting and wearing outer garments. The body mass index (BMI) was calculated as kg/m 2 (weight/ height).
Statistical Analyses
SPSS software package (SPSS 15; SPSS Inc, Chicago, IL) was used for statistical analyses. The data were analyzed using Student's t-test and the numeric data were expressed as the mean + standard deviation. Categorical data were analyzed with a w 2 test, and the results were expressed in percentages. For correlation analysis, Spearman and Pearson correlation analyses were used. Multivariate logistic regression analysis was used to compare the risk factors for AVS. A P < .05 was considered statistically significant.
Results
The mean values and statistical comparisons of 210 patients are presented in Table 1 . A statistically significant difference was obtained between the 2 groups in respect to DM, HT, and smoking status, which are considered as risk factors for AVS. Similarly, a significant difference was observed between the groups in terms of age, MPV, and PDW, whereas the groups had similar ratios regarding platelet and WBC counts (P > .05). Similarly a significant difference was observed between the groups in terms of ascending aortic diameter and left ventricular mass index (P < .05). When the groups were compared in terms of BMI, height, weight, body surface area, early/atrial (E/A) ratio, EF, and TC, TG, HDL-C, and LDL-C levels, no statistically significant differences were existed (P > 0.05).
Although the platelet count was lower in the AVS (þ) group than the AVS (À) group, it was not statistically significant (P > .05). In our study, it was determined that as the platelet count are increased, the MPV (r ¼ À.194, P ¼ .003) and PDW (r ¼ À.212, P ¼ .001) values are decreased. A negative correlation existed between age and platelet count (r ¼ À.208, P ¼ .029), whereas there was a positive correlation between age and MPV (r ¼ .199, P ¼ .004). The MPV was 8.41 + 0.64 fL in male participants and 8.46 + 0.77 fL in female participants; this difference was not statistically significant (P > .05).
When Pearson correlation analysis was performed between the clinical, echocardiographic, and laboratory parameters, positive correlations of AVS with age (r ¼ .461, P ¼ .001), MPV (r ¼ .146, P ¼ .034), PDW (r ¼ .385, P ¼ .001), HT (r ¼ .263, P < .001), DM (r ¼ .178, P ¼ .012), smoking (r ¼ .173, P ¼ .017) and LVMI (r ¼ .162, P ¼ .05) were noted ( Table 2) .
Discussion
In the current study, the MPV and PDW which are easily measured during a routine CBC were higher in the patients with AVS than the control group. The MPV is one of the important platelet production indices that may relate with platelet function. High-volume platelets might be metabolically more active than those with lower volumes. Alterations in the diameter and the activity of platelets may cause thrombus formation within the coronary arteries. 16 Thrombus formation or mural thrombi on the atherosclerotic lesions are observed in almost every phase of atherogenesis. Thrombus formation is also implicated in the structure of aortic stenosis. 11, 12 In case of any factorstimulating platelet production, not only the MPV but also the PDW is increased. 17, 18 In the present study, we determined that MPV was decreased by the increase in platelet count. A negative correlation between age and platelet count and a positive correlation between age and MPV were detected. There was no significant difference between female and male participants in terms of MPV and PDW. Our findings are consistent with the results of Keskin et al. 19 Mean platelet volume has been reported to be increased as a consequence of acute ischemic events and return to normal thereafter. Persistently high levels of MPV have been suggested to be associated with complications and not correlated with other risk factors, and MPV is a finding in acute coronary syndromes. Mean platelet volume levels have been reported to be increased as a consequence of acute alterations in atherosclerotic processes, rather than a predictive parameter for atherosclerotic processes. 19 In our study, no correlation was observed between the platelet count, MPV and gender, smoking. In studies that have compared similar risk factors with platelet function, no clear correlation was demonstrated. 19 In a recent study, platelet hyperaggregability and increased platelet aggregation in response to adenosine diphosphate (ADP), and reduced antiaggregant properties to sodium nitroprusside (SNP), which is a donor of nitric oxide (NO) with antiaggregant properties, have been reported in patients with AVS. 20 Various types of matrix metalloproteinase have been reported in platelets. 21 There are also studies demonstrating an association between increased matrix metalloproteinase and calcific aortic valves. 22, 23 The MPV has been reported to be increased in acute myocardial infarction, acute cerebral ischemia, and transient ischemic attack. 24 In a study by Deniz et al, 25 it has been reported that increased MPV in ischemic stroke patients returns to normal in time and persistently high levels are associated with a poor prognosis. Increased platelet activation contributes to the increased risk of cardiovascular diseases in the case of impaired glucose tolerance. 26 Role of MPV, which might be potentially an indicator of platelet activation, in the atherothrombosis formation need to be clarified in further studies.
Studies have demonstrated a strong correlation of AVS with age and HT, and between the presence of dyslipidemia and DM. [27] [28] [29] [30] In the Helsinki Aging study, HT and age have been reported as independent risk factors for aortic valve calcification. 27 Our findings are consistent with the literature. The presence of traditional risk factors for atherosclerosis, such as increased TC, LDL-C, lipoprotein(a), and TG, and decreased HDL-C, male gender, smoking, HT, and DM have been demonstrated to increase the frequency of AVS. These risk factors are considered to be the possible causes of endothelial dysfunction and valvular damage.
27,31-35 Platelets play a key role in atherosclerosis due to HT and in the development of acute complications. 36, 37 In patients with hypertension, platelets represent an increase in activation and aggregation. Abnormal alteration in platelet activation causes a prothrombotic state in patients with hypertension. 38 Although the reason for increased MPV in cardiovascular disease is controversial, it is considered to be caused by platelet activation due to arterial wall damage, together with other factors, the presence of circulating platelet activation stimulators, and genetic predisposition. 39 Because larger platelets are metabolically more active, platelet volume might be one of the determinants of platelet function. 40 Large platelets are more prone to adhesion and aggregation. Increased MPV, which indicates a larger platelet volume, is assessed as an indicator of the platelet function and activation and hence suggested as the marker of increased risk of cardiovascular diseases. 41, 42 There are several studies which have reported that at least 20% of ischemic strokes are of cardiac origin and the presence of calcific aortic valves is a risk factor for thromboembolism in the etiology of cerebral strokes. 43 Similarly, an increased MPV is higher in patients with acute ischemic strokes compared to a control group. [44] [45] [46] In our study, a strong positive correlation of AVS with MVP and PDW was demonstrated.
Aortic valve sclerosis is a progressive clinical condition frequently encountered in clinical practice, affecting about 21% to 26% of the elderly population >65 years. 47 In addition, in our study, the mean age was found to be significantly higher in the AVS (þ) group compared to the control group.
Study Limitations
None of platelet function tests like optical platelet aggregation were made in this study; thus, inference of status of platelet activity cannot be determined solely on this increased platelet production. Additionally, cause and result relationship between increased platelet production and AVS need to be determined.
Conclusion
Our study revealed that platelet production indices including MPV and PDW were increased in patients with AVS. The complex interrelationship between increased platelet production indices and AVS and value of antithrombotic therapies in patients with AVS need to be evaluated in further studies.
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